Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Negative affective bias in depression following treatment with psilocybin or escitalopram - a secondary analysis from a randomized trialTranslational Psychiatry · 2025-11-12Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreatFrontiers in Psychiatry · 2025-08-05Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge studyComprehensive Psychiatry · 2025-07-01Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprisesMolecular Psychiatry · 2025-04-25Study Protocol for ‘PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity’Cureus · 2025-01-28Effects of escitalopram and psilocybin therapy on mesolimbic resting-state functional connectivity in depressionNeuroscience Applied · 2024-12-31Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trialEClinicalMedicine · 2024-09-22Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapyScientific Reports · 2024-07-16Study protocol for “Psilocybin in patients with fibromyalgia: brain biomarkers of action”Frontiers in Psychiatry · 2024-06-03Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depressionJournal of Psychopharmacology · 2024-03-21Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive DisorderInternational Journal of Mental Health and Addiction · 2024-03-06Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivityJournal of Affective Disorders · 2024-02-26Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depressionPsychological Medicine · 2024-01-21Psilocybin vs Escitalopram for depression: 6-month follow-upNeuroscience Applied · 2023-12-31Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiencesScientific Reports · 2023-08-21Personality change in a trial of psilocybin therapy v. escitalopram treatment for depressionPsychological Medicine · 2023-06-01A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depressionJournal of Psychopharmacology · 2023-04-24Psilocybin as a treatment for anorexia nervosa: 6-week and 3-month follow-up resultsNeuroscience Applied · 2022-12-31Body mass index (BMI) does not predict responses to psilocybin.Journal of Psychopharmacology · 2022-11-13A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression.Psychedelic Medicine · 2022-10-27Effects of psilocybin versus escitalopram on rumination and thought suppression in depression.BJPsych Open · 2022-09-05Increased global integration in the brain after psilocybin therapy for depression.Nature Medicine · 2022-04-10Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.Frontiers in Pharmacology · 2022-03-30P.0353 Study protocol: psilocybin as a treatment for anorexia nervosa: a pilot studyEuropean Neuropsychopharmacology · 2021-11-30P.0828 Psilocybin enhances emotional response to music in healthy individualsEuropean Neuropsychopharmacology · 2021-11-30Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study".Frontiers in Psychiatry · 2021-10-19Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample.Frontiers in Psychiatry · 2021-06-28Trial of Psilocybin versus Escitalopram for Depression.New England Journal of Medicine · 2021-03-31Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humansJournal of Psychopharmacology · 2020-10-07P.839 Modelling the acute temporal dynamics of psilocybin psychoactive effects; relation to brain serotonin 2a receptor levelsEuropean Neuropsychopharmacology · 2019-11-30Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levelsNeuropsychopharmacology · 2019-01-25Psilocybin occupancy of brain serotonin 2A receptors correlates with psilocin levels and subjective experience: a [11C]Cimbi-36 PET study in humansEuropean Neuropsychopharmacology · 2018-12-31Effects of psilocybin therapy on personality structure.Acta Psychiatrica Scandinavica · 2018-06-18Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.Psychopharmacology · 2017-11-07Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.The Lancet Psychiatry · 2016-05-16Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis.Schizophrenia Bulletin · 2012-10-07Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases.Human Psychopharmacology Clinical and Experimental · 2012-06-13Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin.The British Journal of Psychiatry · 2012-01-25Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.Proceedings of the National Academy of Sciences · 2012-01-22P.1.e.017 The functional brain correlates of the psychedelic state: an arterial spin labelling study with psilocybinEuropean Neuropsychopharmacology · 2011-08-06